Patents Assigned to Foundation
  • Patent number: 10534076
    Abstract: Shear waves are generated and measured in viscoelastic phantoms by a single push beam. Using numerical simulations or an analytical function to describe the diffraction of the shear wave, the resulting shear wave motion induced by the applied push beam is calculated with different shear elasticity values and then convolved with a separate expression that describes the effects of viscosity value for the medium. The optimization algorithm chooses the tissue parameters which provide the smallest difference between the measured shear waveform and the simulated shear waveform. A shear viscosity image is generated by applying such optimization procedure at all of the observation points.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: January 14, 2020
    Assignees: Board of Trustees of Michigan State University, Mayo Foundation for Medical Education and Research
    Inventors: Robert J. McGough, Yiqun Yang, Matthew W. Urban
  • Patent number: 10536388
    Abstract: Provided are an apparatus and a method for scheduling contention-based data transmission in a network system including an access point (AP) and a plurality of terminals. The method includes determining a contention window (CW) size based on the number of terminals connected to the access point, and transmitting information about the contention window size to any one of the plurality of terminals. The apparatus includes a processor and an RF unit. Here, the processor is configured to determine a contention window (CW) size based on the number of terminals connected to the access point, and transmit information on the contention window size to any one of the plurality of terminals through the RF unit.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: January 14, 2020
    Assignee: Research & Business Foundation Sungkyunkwan University
    Inventors: Tae-Jin Lee, Youngil Cho, Ji Hyoung Ahn
  • Patent number: 10531810
    Abstract: This document provides devices and methods for the treatment of heart conditions. For example, this document provides devices and methods for detecting heart rotors such that effectively targeted cardiac fibrillation treatments can be provided.
    Type: Grant
    Filed: July 22, 2015
    Date of Patent: January 14, 2020
    Assignee: Mayo Foundation for Medical Education and Research
    Inventor: Komandoor Srivathsan
  • Patent number: 10536924
    Abstract: The present disclosure relates to a pre-5th-Generation (5G) or 5G communication system to be provided for supporting higher data rates Beyond 4th-Generation (4G) communication system such as Long Term Evolution (LTE). A method for operating of a terminal in a wireless communication system according to an exemplary embodiment includes: receiving signals from other terminals; selecting another terminal which has proximity to the terminal from among the other terminals based on reception powers of the signals and information related to the signals; and determining a location of the terminal based on location information of the other terminals.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: January 14, 2020
    Assignees: Samsung Electronics Co., Ltd., Research & Business Foundation Sungkyunkwan University
    Inventors: Wonjun Hwang, Hyung-Jin Choi, Han Jun Kim, Kyunghoon Lee, Hyunseok Ryu, Min Jang
  • Patent number: 10533959
    Abstract: A sample holding device and related method designed to facilitate inexpensive and reliable testing of materials or specimens with beam diffraction and scattering techniques. The device features a sample receptacle that is made out of a polymer, cellulose, polymeric material, or cellulosic material. The flexible nature and low melting point of the sample receptacle allows for reliable sealing against the vacuum or gaseous environment used for beam diffraction or scattering analysis. The sample holding device can be considered disposable because of its low cost, eliminating the need for complex or unreliable cleaning procedures.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: January 14, 2020
    Assignee: University of Virginia Patent Foundation
    Inventors: Michael C. Wiener, Peter Horanyi
  • Patent number: 10533187
    Abstract: Provided are nucleic acid sequences, recombinant adeno-associated viral particles, compositions, and methods related to treating cone monochromacies, such as blue cone monochromacy (BCM). Specifically, the nucleic acid sequences, recombinant adeno-associated viral particles, compositions, and methods involve use of an M-opsin gene operably linked to a cone-specific promoter. Further disclosed is the sequence of a cone-specific PR2.1 promoter.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: January 14, 2020
    Assignee: University of Florida Research Foundation, Incorporated
    Inventors: William W. Hauswirth, Ji-Jing Pang
  • Patent number: 10536040
    Abstract: Provided are a control method for a wireless power transfer apparatus considering interference in wireless powered communication networks, and a wireless power transfer apparatus. The control method of the wireless power transfer apparatus includes: performing, by at least one wireless power transfer apparatus, a distributed coordination function (DCF) based contention process with at least one wireless communication terminal; and transmitting, by the wireless power transfer apparatus which won in the DCF based contention process, an energy frame to the at least one wireless communication terminal.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: January 14, 2020
    Assignee: Research & Business Foundation Sungkyunkwan University
    Inventors: Tae-Jin Lee, Ji Hyoung Ahn, Seung Yong Jeon, Min Young Chung
  • Patent number: 10536036
    Abstract: An integrated circuit, such as included as a portion of a sensor node, can include a regulator circuit having an input coupleable to an energy harvesting transducer. The integrated circuit can include a wireless receiver circuit coupled to the regulator circuit and configured to wirelessly receive at least enough operating energy to establish operation of the sensor node without requiring the energy harvesting transducer. The integrated circuit can include a digital processor circuit coupled to the regulator circuit and a power management processor circuit. The digital processor circuit or one or more other circuits can include a subthreshold operational mode established by the power management processor circuit based on the selected energy consumption level. For example, establishing the subthreshold operational mode can include adjusting or selecting a supply voltage so as to establish subthreshold operation of a field effect transistor (FET) in the digital processor circuit or other circuits.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: January 14, 2020
    Assignees: University of Virginia Patent Foundation, University of Washington through its Center for Commercialization
    Inventors: Benton H. Calhoun, Brian Otis
  • Patent number: 10536256
    Abstract: Disclosed is a 5G or pre-5G communication system for supporting a data transmission rate higher than that of a 4G communication system, such as LTE, and subsequent systems, and a method for transmitting an uplink control signal in a wireless communication system comprises the steps of: transmitting information indicating a first frequency domain to which an uplink control signal is transmitted from a base station, which has determined to perform full-duplex based communication; and performing downlink reception through the remaining frequency domains excluding the first frequency domain.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: January 14, 2020
    Assignees: Samsung Electronics Co., Ltd., Yonsei University-Industry Foundation
    Inventors: Hyoung-Ju Ji, Dae-Sik Hong, Youn-Sun Kim, Jong-Hyun Bang, Hyun-Soo Kim
  • Patent number: 10533226
    Abstract: The gene responsible for encoding SERT has a functional polymorphism at the 5?-regulatory promoter region, which results in two forms, long (L) and short (S). The LL-genotype is hypothesized to play a key role in the early onset of alcohol use. The present invention discloses the differences in treatment and diagnosis based on the L or short genotypes as well as on a single nucleotide polymorphism of the SERT gene, the 3? UTR SNP rs1042173. The present invention demonstrates the efficacy of using the drug ondansetron and similar drugs for treatment based on variations in the polymorphisms of the SERT gene as well as methods for diagnosing susceptibility to abuse of alcohol and other addiction-related diseases and disorders.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: January 14, 2020
    Assignee: University of Virginia Patent Foundation
    Inventor: Bankole A. Johnson
  • Publication number: 20200010664
    Abstract: The present application generally relates to epoxy/tannin reaction product compositions, and methods of making and using the epoxy tannin reaction product compositions. The epoxy/tannin reaction product compositions are hardened thermosetting polymeric materials, are substantially homogeneous and substantially free of visible clumps, and have a glass transition temperature of at least 140° C.
    Type: Application
    Filed: February 27, 2018
    Publication date: January 9, 2020
    Applicant: Purdue Research Foundation
    Inventors: Jeffrey Paul Youngblood, John A. Howarter, Matthew N. Korey
  • Publication number: 20200012896
    Abstract: Provided is an apparatus for generating data based on generative adversarial networks (GANs), the apparatus including a first generator configured to receive input data and generate a first fake image and a first discriminator configured to receive the first fake image generated by the first generator and a first real image and verify whether an image is fake or real.
    Type: Application
    Filed: December 4, 2018
    Publication date: January 9, 2020
    Applicant: Kwangwoon University Industry-Academic Collaboration Foundation
    Inventors: Ji Sang YOO, Ju Won KWON
  • Publication number: 20200013479
    Abstract: A spin transfer torque magnetic random access memory (STT-MRAM) device according to the present embodiment comprises: an STT-MRAM memory array which includes a data storage unit for storing data, a defect area address storage unit for storing an address of a defect area, and a spare area for storing data of a failed area; and a bypass determination unit which includes a volatile information storage element for storing the address of the defect area, stored in the defect area address storage unit and provided thereto, and when memory array access occurs, compares an access address with the address of the defect area stored in the volatile information storage element and causes the memory array access to bypass to the spare area.
    Type: Application
    Filed: March 16, 2018
    Publication date: January 9, 2020
    Applicant: Industry-University Cooperation Foundation Hanyang University
    Inventors: Sang-Gyu PARK, Dong-Gi LEE
  • Publication number: 20200012761
    Abstract: Systems and methods for diagnosing prostate cancer. Image sets (e.g., MRI collected at one or more b-values) and biological values (e.g., prostate specific antigen (PSA)) have features extracted and integrated to produce a diagnosis of prostate cancer. The image sets are analyzed primarily in three steps: (1) segmentation, (2) feature extraction, smoothing, and normalization, and (3) classification. The biological values are analyzed primarily in two steps: (1) feature extraction and (2) classification. Each analysis results in diagnostic probabilities, which are then combined to pass through an additional classification stage. The end result is a more accurate diagnosis of prostate cancer.
    Type: Application
    Filed: July 9, 2018
    Publication date: January 9, 2020
    Applicant: University of Louisville Research Foundation, Inc.
    Inventors: Ayman S. El-Baz, Ahmed Shalaby, Fahmi Khalifa, Islam Abdelmaksoud
  • Publication number: 20200009208
    Abstract: The present invention relates to a composition for preventing or treating a muscle disorder, which includes a chrysanthemum extract or 3,5-dicaffeoylquinic acid as an active ingredient, and specifically, it may be used to reduce mRNA expression of atrogin-1 and MuRF1, which are main biomarkers involved in muscle protein degradation and increase mRNA expression of the mTOR protein, which is a main biomarker involved in muscle protein formation, and myogenin and MyoD, which are biomarkers related to muscle differentiation, thereby reducing muscle loss, and thus the chrysanthemum extract or 3,5-dicaffeoylquinic acid can be used in prevention and treatment of a muscle disorder, or improvement in muscle function. In addition, the chrysanthemum extract or 3,5-dicaffeoylquinic acid increases the activity of SIRT1 and PGC-1?, which are the main biomarkers involved in exercise performance, thereby excellently enhancing exercise performance.
    Type: Application
    Filed: November 30, 2017
    Publication date: January 9, 2020
    Applicants: Industry-Academic Cooperation Foundation, Yonsei University, Cosmax NBT, Inc., Cosmax NS, Inc.
    Inventors: Jae Kwan HWANG, Jun Gon YUN, Mi Bo KIM, Chang Hee KIM, Joon Hyung LEE, Do Wan KWON, Su Young CHOI, Jin Hak KIM, Ji Hwan JANG, Jeong Ho GEUM, Min Son KWEON
  • Publication number: 20200010958
    Abstract: A method for enhancing corrosion resistance of a solid material exposed to a liquid. The method includes providing a solid material which can form a solid product layer when exposed to the corrosive liquid, and maintaining the concentration of the solid product material in the liquid either at saturation or elevated level. A materials system containing a solid material capable of forming a solid product layer when exposed to air or a liquid environment containing dissolved oxygen at levels sufficient for oxidation of at least one constituent of the solid material, wherein the solid product layer is in contact with a liquid containing an elevated or saturated concentration of the dissolved solid product layer. A corrosion-resistant device containing a solid material with a solid-product layer exposed to a molten salt solution, wherein the concentration of the solid-product dissolved in the molten salt solution is at saturation or elevated level.
    Type: Application
    Filed: March 16, 2018
    Publication date: January 9, 2020
    Applicant: Purdue Research Foundation
    Inventor: Kenneth H. Sandhage
  • Publication number: 20200010432
    Abstract: The present invention provides novel phenazine derivatives, such as compounds of Formula (I) (e.g., Formulae (II)-(XIX)), and pharmaceutically acceptable salts thereof. The compounds of the invention are expected to be antimicrobial agents and may act by a microbial warfare strategy (e.g., a reactive oxygen species (ROS)-based competition strategy). The present invention also provides pharmaceutical compositions, kits, uses, and methods that involve the compounds of the invention and may be useful in preventing or treating a microbial infection (e.g., a bacterial infection or mycobacterial infection) in a subject, inhibiting the growth and/or reproduction of a microorganism (e.g., a bacterium or mycobacterium), killing a microorganism (e.g., a bacterium or mycobacterium), inhibiting the formation and/or growth of a biofilm, reducing or clearing a biofilm, and/or disinfecting a surface.
    Type: Application
    Filed: February 17, 2018
    Publication date: January 9, 2020
    Applicant: University of Florida Research Foundation, Incorporated
    Inventors: Robert William Huigens, III, Aron Garrison, Yasmeen Abouelhassan, Hongfen Yang, Gena Burch
  • Publication number: 20200010821
    Abstract: Cell-targeted serine protease constructs are provided. Such constructs can be used in methods for targeted cell killing such as for treatment cell of proliferative diseases (e.g., cancer). In some aspects, recombinant serine proteases, such as Granzyme B polypeptides, are provided that exhibit improved stability and cell toxicity. Methods and compositions for treating lapatinib or trastuzumab-resistant cancers are also provided.
    Type: Application
    Filed: September 19, 2019
    Publication date: January 9, 2020
    Applicant: Research Development Foundation
    Inventors: Michael G. ROSENBLUM, Khalid Amanali MOHAMEDALI, Lawrence H. CHEUNG
  • Publication number: 20200013946
    Abstract: A sensor is disclosed which includes a piezoelectric layer, a piezoresistive layer, one or more electrode layers coupled to the piezoelectric layer and to the piezoresistive layer, the piezoelectric layer configured to provide an electrical signal in response to application of a dynamic disturbance, and the piezoresistive layer configured to provide a change in resistivity in response to application of a static disturbance.
    Type: Application
    Filed: September 16, 2019
    Publication date: January 9, 2020
    Applicant: Purdue Research Foundation
    Inventors: Mukerrem Cakmak, Armen Yildirim, Rahim Rahimi, Saeed Mohammadi, Ali Shakouri
  • Publication number: 20200009248
    Abstract: Materials and methods for treating cholangiopathies by targeting TGR5, including materials and methods for treating cholangiopathies such as polycystic liver disease, are provided herein.
    Type: Application
    Filed: July 24, 2019
    Publication date: January 9, 2020
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Tetyana V. Masyuk, Nicholas F. LaRusso, Anatoliy Masyuk